ASTEC

ASTEC LIFESCIENCES

Small Cap BSE: 533138 NSE: ASTEC
₹1874.6
-16.15 (-0.85%)
As on 20 August, 2022 | 11:59

Astec Lifesciences Share Price

Astec Lifesciences Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Astec Lifesciences Share Returns

  • Over 1 Month -8.7%
  • Over 3 Month 4.51%
  • Over 6 Month 15.79%
  • Over 1 Year 42.2%

Astec Lifesciences Key Statistics

P/E Ratio 41.6
PEG Ratio 1
Market Cap Cr 3,675
Price to Book Ratio 9.3
EPS 45.8
Dividend 0.1
Relative Strength Index 45.97
Money Flow Index 74.27
MACD Signal -3.02
Average True Range 66.53

Astec Lifesciences Investment Rating

  • Master Rating:
  • Astec Lifesciences has an operating revenue of Rs. 732.18 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of 18% is great, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -10% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 44 indicates it belongs to a fair industry group of Chemicals-Agricultural and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Astec Lifesciences Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 184
  • 272
  • 173
  • 103
  • 129
  • 172
  • Operating Expenses Qtr Cr
  • 159
  • 207
  • 130
  • 81
  • 104
  • 134
  • Operating Profit Qtr Cr
  • 25
  • 65
  • 43
  • 21
  • 25
  • 38
  • Depreciation Qtr Cr
  • 9
  • 11
  • 9
  • 8
  • 7
  • 7
  • Interest Qtr Cr
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • Tax Qtr Cr
  • 4
  • 15
  • 8
  • 3
  • 4
  • 8
  • Net Profit Qtr Cr
  • 11
  • 43
  • 25
  • 9
  • 13
  • 24

Astec Lifesciences Technicals

EMA & SMA

Current Price
1874.6
-16.15 (-0.85%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • 1899.35
  • 50 Day
  • 1882.3
  • 100 Day
  • 1819.26
  • 200 Day
  • 1673.58
  • 20 Day
  • 1890.41
  • 50 Day
  • 1885.55
  • 100 Day
  • 1838.19
  • 200 Day
  • 1674.62

Astec Lifesciences Resistance and Support

PIVOT
₹1895.29
Resistance
  • First Resistance
  • 1910.47
  • Second Resistance
  • 1930.19
  • Third Resistance
  • 1945.37
Support
  • First Resistance
  • 1875.57
  • Second Resistance
  • 1860.39
  • Third Resistance
  • 1840.67
  • RSI
  • 45.97
  • MFI
  • 74.27
  • MACD Single Line
  • -3.02
  • MACD
  • -5.7

Astec Lifesciences Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 12,462
  • 550,945
  • 44.21
  • Week
  • 16,058
  • 439,501
  • 27.37
  • 1 Month
  • 48,101
  • 2,834,108
  • 58.92
  • 6 Month
  • 42,678
  • 2,231,607
  • 52.29

Astec Lifesciences Result Highlights

Astec Lifesciences Synopsis

NSE-Chemicals-Agricultural

Astec Lifesciences L is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 676.57 Cr. and Equity Capital is Rs. 19.60 Cr. for the Year ended 31/03/2022. Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236.
  • Market Cap
  • 3,675
  • Sales
  • 732
  • Shares in Float
  • 0.69
  • No of funds
  • 34
  • Yield
  • 0.08
  • Book Value
  • 9.28
  • U/D Vol ratio
  • 1.2
  • LTDebt / Equity
  • 13
  • Alpha
  • 0.14
  • Beta
  • 1.04

Astec Lifesciences

  • Owner Name

Astec Lifesciences Management

  • Name
  • Designation

Astec Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Astec Lifesciences Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-25
  • Quarterly Results
  • 2022-05-02
  • Audited Results & Final Dividend
  • 2022-01-25
  • Quarterly Results
  • 2021-10-27
  • Quarterly Results
  • 2021-07-28
  • Quarterly Results

Astec Lifesciences MF Shareholding

  • Name
  • Amount(cr)
  • Nippon India Small Cap Fund - Growth
  • 20363
  • Nippon India Multi Cap Fund - Growth
  • 12638
  • ICICI Prudential Multicap Fund Growth
  • 6720
  • ICICI Prudential Smallcap Fund Growth
  • 3979
  • UTI Small Cap Fund Regular Growth
  • 2177

Astec Lifesciences FAQs

What is Share Price of Astec Lifesciences ?

Astec Lifesciences share price is ₹1874 As on 20 August, 2022 | 11:45

What is the Market Cap of Astec Lifesciences ?

The Market Cap of Astec Lifesciences is ₹3675.1 Cr As on 20 August, 2022 | 11:45

What is the P/E ratio of Astec Lifesciences ?

The P/E ratio of Astec Lifesciences is 41.6 As on 20 August, 2022 | 11:45

What is the PB ratio of Astec Lifesciences ?

The PB ratio of Astec Lifesciences is 9.3 As on 20 August, 2022 | 11:45

Q1FY23